Zhi-qin Li
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial.
Journal: The American journal of gastroenterology
Published: August 20, 2024
Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 10, 2021
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 25, 2020
Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels.
Journal: Open forum infectious diseases
Published: May 05, 2020
On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
Journal: World journal of gastroenterology
Published: March 06, 2019
Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels.
Journal: Journal of cellular biochemistry
Published: September 05, 2018
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study.
Journal: Journal of hepatology
Published: October 03, 2016
The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors.
Journal: Clinics and research in hepatology and gastroenterology
Published: March 31, 2016
Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling.
Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling.
Journal: Bioscience reports
Published: January 04, 2016
The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection.
Journal: Archives of virology
Published: November 18, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026